Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» lupus
lupus
Eli Lilly, Incyte axe Olumiant in lupus amid eczema stalemate at FDA
Fierce Pharma
Fri, 01/28/22 - 11:47 am
Eli Lilly
Incyte
olumiant
FDA
lupus
eczema
Idorsia sets itself up for failure
EP Vantage
Mon, 11/1/21 - 10:57 pm
Idorsia
cenerimod
lupus
clinical trials
AstraZeneca's launch plan for first-in-class lupus med Saphnelo centers on patient-designed support program
Fierce Pharma
Tue, 08/3/21 - 11:13 am
AstraZeneca
drug launches
lupus
Saphnelo
patient advocacy groups
AstraZeneca nabs FDA nod to challenge GSK's Benlysta with first-in-class lupus drug Saphnelo
Fierce Pharma
Mon, 08/2/21 - 11:08 am
AstraZeneca
GSK
FDA
lupus
Saphnelo
systemic lupus erythematosus
Benlysta
GlaxoSmithKline debuts DTC campaign for lupus med Benlysta as it looks to cement category lead
Fierce Pharma
Tue, 07/27/21 - 04:24 pm
GSK
lupus
Benlysta
DTC advertising
Biogen (BIIB) Initiates Late-Stage Study on Lupus Candidate
Yahoo/Zacks.com
Mon, 06/21/21 - 10:54 am
Biogen
lupus
clinical trials
BIIB059
Progentec’s Novel Blood Test Predicts Lupus Flares Up to 12 Weeks Before They Occur
BioSpace
Mon, 09/21/20 - 10:51 am
Progentec Diagnostics
diagnostics
lupus
SLE
J&J scraps late-stage study testing Stelara for lupus
Reuters
Sat, 06/27/20 - 11:40 pm
JNJ
Janssen
lupus
Stelara
clinical trials
AbbVie beefs up the immunology pipeline, betting up to $865M on a PhII-ready drug — and fueling a biotech stock frenzy
Endpoints
Thu, 06/18/20 - 10:55 am
AbbVie
Mitchell Gold
Dendreon
ALPN-101
immunology
Alpine Immune Sciences
lupus
How a Seattle Genetics cancer drug could help lupus patients with kidney damage
Fierce Biotech
Thu, 04/9/20 - 10:35 am
Seattle Genetics
lupus
kidney damage
PX-478
AstraZeneca lupus drug shows potential, but it may not be enough for FDA
Biopharma Dive
Thu, 12/19/19 - 01:05 pm
AstraZeneca
lupus
anifrolumab
GSK
Benlysta
GlaxoSmithKline's Benlysta eyes lupus sales boost after kidney trial win
Fierce Pharma
Wed, 12/18/19 - 10:54 am
GSK
Benlysta
lupus
'Positive surprise' for Biogen in lupus, but all eyes on CTAD data this week
Fierce Biotech
Tue, 12/3/19 - 10:20 pm
Biogen
AstraZeneca
lupus
Amgen clinical trials
BIIB059
AstraZeneca plans 2020 filing for anifrolumab in lupus
Fierce Biotech
Tue, 11/12/19 - 10:25 am
AstraZeneca
FDA
lupus
anifrolumab
Roche steers Gazyva into a new PhIII program after combo shows promise in lupus nephritis study
Endpoints
Mon, 11/11/19 - 11:04 am
Roche
monoclonal antibodies
Gazyva
lupus
kidney disease
clinical trials
Gilead’s filgotinib fails midphase tests in lupus, Sjogren's
Fierce Biotech
Fri, 10/25/19 - 10:39 am
Gilead Sciences
filgotinib
lupus
Sjögren’s syndrome
clinical trials
Upcoming events – Sage targets depression and Biogen aims for lupus
EP Vantage
Fri, 10/4/19 - 10:03 am
SAGE Therapeutics
SAGE-217
major depressive disorder
Biogen
BIIB059
lupus
One year after flop, AstraZeneca's phase 3 lupus trial hits endpoint
Fierce Biotech
Thu, 08/29/19 - 10:30 am
AstraZeneca
clinical trials
anifrolumab
systemic lupus erythematosus
lupus
Beyond cancer: CAR T cells treat lupus in mice
BioCentury
Thu, 03/7/19 - 09:30 pm
CAR-T
lupus
Biogen sees two phase 2 failures: In sciatica and in its lupus collaboration with UCB
Fierce Biogen
Tue, 10/23/18 - 01:40 pm
UCB Pharma
Biogen
dapirolizumab pegol
vixotrigine
lupus
sciatica
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »